APA

Caenepeel S., Cooke K., Wadsworth S., Huang G., Robert L., Moreno B. H., Parisi G., Cajulis E., Kendall R., Beltran P., Ribas A., Coxon A. & Hughes P. E. (20170907). MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor. : Oncotarget.

Chicago

Caenepeel Sean, Cooke Keegan, Wadsworth Sarah, Huang Guo, Robert Lidia, Moreno Blanca Homet, Parisi Giulia, Cajulis Elaina, Kendall Richard, Beltran Pedro, Ribas Antoni, Coxon Angela and Hughes Paul E. 20170907. MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor. : Oncotarget.

Harvard

Caenepeel S., Cooke K., Wadsworth S., Huang G., Robert L., Moreno B. H., Parisi G., Cajulis E., Kendall R., Beltran P., Ribas A., Coxon A. and Hughes P. E. (20170907). MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor. : Oncotarget.

MLA

Caenepeel Sean, Cooke Keegan, Wadsworth Sarah, Huang Guo, Robert Lidia, Moreno Blanca Homet, Parisi Giulia, Cajulis Elaina, Kendall Richard, Beltran Pedro, Ribas Antoni, Coxon Angela and Hughes Paul E. MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor. : Oncotarget. 20170907.